XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock Class A
Common Stock Class B
Common Stock
Common Stock
Common Stock Class A
Common Stock
Common Stock Class B
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021         170,625,994 9,842,105      
Balance at Dec. 31, 2021 $ 11,031,466       $ 168 $ 12 $ 13,169,118 $ (18,141) $ (2,119,691)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss attributable to common stockholders (221,627)               (221,627)
Exercises of vested stock options (in shares)         180,643 193,889      
Exercises of vested stock options 11,727           11,727    
Vesting of restricted stock units (in shares)         877,089        
Vesting of restricted stock units 0       $ 1   (1)    
Value of equity awards withheld for tax liability (in shares)         (5,804)        
Value of equity awards withheld for tax liability (1,065)           (1,065)    
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)         215,389 (215,389)      
Shares of Class A common stock issued and donated to charity (in shares)         22,102        
Shares of Class A common stock issued and donated to charity 4,232           4,232    
Shares returned from escrow (in shares)         (152,239)        
Shares returned from escrow (387)           (387)    
Unrealized gain (loss) on marketable securities (62,826)             (62,826)  
Foreign currency translation (165)             (165)  
Net change in market value of effective foreign currency forward exchange contracts (3,852)             (3,852)  
Share of other comprehensive income from equity method investment 0                
Stock-based compensation 159,930           159,930    
Ending balance (in shares) at Mar. 31, 2022         171,763,174 9,820,605      
Balance at Mar. 31, 2022 10,917,433       $ 169 $ 12 13,343,554 (84,984) (2,341,318)
Beginning balance (in shares) at Dec. 31, 2022   176,358,104 9,617,605   176,358,104 9,617,605      
Balance at Dec. 31, 2022 10,559,042       $ 174 $ 12 14,055,853 (121,161) (3,375,836)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss attributable to common stockholders (342,139)               (342,139)
Exercises of vested stock options (in shares)         66,968 97,199      
Exercises of vested stock options 3,264           3,264    
Vesting of restricted stock units (in shares)         1,516,634        
Vesting of restricted stock units 0       $ 2   (2)    
Value of equity awards withheld for tax liability (in shares)         (36,965)        
Value of equity awards withheld for tax liability (2,456)           (2,456)    
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)         97,199 (97,199)      
Shares of Class A common stock issued and donated to charity (in shares)         22,102        
Shares of Class A common stock issued and donated to charity 1,599           1,599    
Unrealized gain (loss) on marketable securities $ 30,750             30,750  
Repurchases of shares of Class A common stock including related costs (in shares) (1,900,000)     (1,902,124)          
Repurchases of shares of Class A common stock including related costs $ (124,992)     $ (2)         (124,990)
Foreign currency translation 483             483  
Net change in market value of effective foreign currency forward exchange contracts 3,335             3,335  
Share of other comprehensive income from equity method investment 14,648             14,648  
Stock-based compensation 164,999           164,999    
Stock-based compensation - restructuring 10,333           10,333    
Ending balance (in shares) at Mar. 31, 2023   176,121,918 9,617,605   176,121,918 9,617,605      
Balance at Mar. 31, 2023 $ 10,318,866       $ 174 $ 12 $ 14,233,590 $ (71,945) $ (3,842,965)